Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single cell mRNA sequencing on esophageal cells of WT and Krt5-CreERT2:R26SmoM2/EYFP (K5:Smo) mice 5 days after Tamoxifen administration

ABSTRACT: In our study, we used single-cell RNA sequencing to investigate the early effects of Hedgehog signaling pathway activation in esophageal progenitors.

ORGANISM(S): Mus musculus

PROVIDER: GSE311819 | GEO | 2026/02/03

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

mRNA sequencing on esophageal cells of Krt5-CreERT2:R26SmoM2/EYFP (K5:Smo) mice, untreated and treated with ibuprofen

Project description:In our study, we used mRNA sequencing to investigate the effect of ibuprofen on the transcriptome of esophageal epithelial cells of K5:Smo mice.

2026-02-03 | GSE291095 | GEO

Single cell mRNA sequencing on esophageal cells of Krt5-CreERT2:R26SmoM2/EYFP (K5:Smo) mice untreated and treated with ibuprofen

Project description:In our study, we used single-cell RNA sequencing to investigate the effect of ibuprofen on cell-mediated communication between esophageal epithelial cells and their microenvironment in K5:Smo mice.

2026-02-03 | GSE291090 | GEO

Single cell mRNA sequencing on esophageal cells of WT and Krt5-CreERT2:R26SmoM2/EYFP (K5:Smo) mice 5 days after Tamoxifen administration

Project description:Single cell mRNA sequencing on esophageal cells of WT and Krt5-CreERT2:R26SmoM2/EYFP (K5:Smo) mice 5 days after Tamoxifen administration

| PRJNA1370951 | ENA

mRNA sequencing on esophageal cells of Krt5-CreERT2:R26SmoM2/EYFP (K5:Smo) mice, untreated and treated with ibuprofen

Project description:mRNA sequencing on esophageal cells of Krt5-CreERT2:R26SmoM2/EYFP (K5:Smo) mice, untreated and treated with ibuprofen

| PRJNA1231540 | ENA

Single cell mRNA sequencing on esophageal cells of Krt5-CreERT2:R26SmoM2/EYFP (K5:Smo) mice untreated and treated with ibuprofen

Project description:Single cell mRNA sequencing on esophageal cells of Krt5-CreERT2:R26SmoM2/EYFP (K5:Smo) mice untreated and treated with ibuprofen

| PRJNA1231534 | ENA

mRNA sequencing on esophageal organoids derived from K5:Smo mice 5 days after tamoxifen injection.

Project description:In our study, we used mRNA sequencing to investigate the effect of 3 days-treatment with a combination of TGFb1 and BMP with or without ibuprofen.

2026-02-03 | GSE294847 | GEO

mRNA sequencing on esophageal organoids derived from K5:Smo mice 5 days after tamoxifen injection.

Project description:mRNA sequencing on esophageal organoids derived from K5:Smo mice 5 days after tamoxifen injection.

| PRJNA1251681 | ENA

ATAC sequencing of esophageal cells from wild type and Krt5SmoM2 mice

Project description:In this study, we used ATAC sequencing to compare the chromatin landscape of esophageal cells in which hedgehog (HH) pathway has been activated (K5SmoM2), to control esophageal cells (WT). We identified more than 50% of the peaks differentially opened in both conditions. Among these differentially opened peaks in EpHI cells, we identified chromatin regions in key columnar markers. Taken together these results show that HH pathway activation triggers chromatin landscape remodeling to facilitate transcommitment.

2021-04-20 | GSE148872 | GEO

In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control.

Project description:Mutant Estrogen Receptor (ERT2) ligand-binding domain fusions with Cre recombinase are a key tool for spatio-temporally controlled genetic recombination with the Cre/lox system. CreERT2 is efficiently activated in a concentration-dependent manner by the Tamoxifen metabolite trans-4-OH-Tamoxifen (trans-4-OHT). Reproducible and efficient Cre/lox experimentation is hindered by the gradual loss of CreERT2 induction potency upon prolonged storage of dissolved trans-4-OHT, which potentially results from gradual trans-to-cis isomerization or degradation. Here, we combined zebrafish CreERT2 recombination experiments and cell culture assays to document the gradual activity loss of trans-4-OHT and describe the alternative Tamoxifen metabolite Endoxifen as more stable alternative compound. Endoxifen retains potent activation upon prolonged storage (3 months), yet consistently induces half the ERT2 domain fusion activity compared to fresh trans-4-OHT. Using 1H-NMR analysis, we reveal that trans-4-OHT isomerization is undetectable upon prolonged storage in either DMSO or Ethanol, ruling out isomer transformation as cause for the gradual loss of trans-4-OHT activity. We further establish that both trans-4-OHT and Endoxifen are insensitive to light exposure under regular laboratory handling conditions. We attribute the gradual loss of trans-4-OHT potency to precipitation over time, and show that heating of aged trans-4-OHT aliquots reinstates their CreERT2 induction potential. Our data establish Endoxifen as potent and reproducible complementary compound to 4-OHT to control ERT2 domain fusion proteins in vivo, and provide a framework for efficient chemically controlled recombination experiments.

| S-EPMC4831813 | biostudies-literature

Mus musculus strain:Krt5-CreERT2

Project description:Mus musculus strain:Krt5-CreERT2 Raw sequence reads

| PRJNA1249066 | ENA